This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.
Device | P080007S012 |
Classification Name | None |
Applicant | |
PMA | P080007 |
Supplement | S012 |
Supplement Number | Date | Supplement Type |
---|---|---|
P080007 | Original Filing | |
S027 | 2022-05-02 | 30-day Notice |
S026 | 2021-08-26 | Real-time Process |
S025 | 2021-07-09 | 30-day Notice |
S024 | 2021-02-25 | 30-day Notice |
S023 | 2020-05-01 | 30-day Notice |
S022 | 2019-06-18 | 30-day Notice |
S021 | 2017-12-15 | 30-day Notice |
S020 | 2014-03-24 | 30-day Notice |
S019 | 2013-12-24 | Special (immediate Track) |
S018 | 2013-08-19 | 30-day Notice |
S017 | 2013-06-04 | 30-day Notice |
S016 | 2013-03-29 | 30-day Notice |
S015 | 2012-11-09 | Normal 180 Day Track No User Fee |
S014 | 2012-05-21 | 30-day Notice |
S013 | 2012-04-02 | 30-day Notice |
S012 | ||
S011 | 2012-02-01 | 135 Review Track For 30-day Notice |
S010 | 2011-11-14 | 30-day Notice |
S009 | 2011-10-28 | 30-day Notice |
S008 | 2011-10-21 | 30-day Notice |
S007 | 2011-09-26 | Real-time Process |
S006 | ||
S005 | 2011-03-11 | 135 Review Track For 30-day Notice |
S004 | 2010-08-12 | 30-day Notice |
S003 | 2010-03-19 | 135 Review Track For 30-day Notice |
S002 | ||
S001 | 2009-01-28 | 30-day Notice |